Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rang-Rang Wang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Dong Xie

    Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China

    2 shared publications
  • Lei-Lei Wu

    Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China

    2 shared publications
  • Feng Jiang

    Deparement of Oncology, Zhongda Hospital Affiliated to Southeast University, Nanjing, 210009, PR China

    1 shared publication
  • Guo-Wei Ma

    Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510000, PR China

    1 shared publication
  • Hai-Hong Yu

    School of Medicine, Tongji University, Shanghai 200092, China

    1 shared publication
  • Haijiao Zhang

    Huadong Hospital Affiliated to Fudan University, Shanghai, China

    1 shared publication

Latest Publications

  • Validation of the 9th edition of the TNM staging system for limited-stage small cell lung cancer after Resection: A multicenter study

    by Leilei Wu, Jia-Yuan Tian, Ming-Jun Li, Feng Jiang, Li-Hong Qiu, Wan-Jun Yu, Xiao-Lu Chen, Rang-Rang Wang, Kun Li, Guo-Wei Ma, et al.


  • Open Access

    Impact of varied immunosuppressive agents and post-transplant diabetes mellitus on prognosis among diverse transplant recipients (experimental studies)

    by Yuan Liu, Jinxin Zheng, Qining He, Haijiao Zhang, Peizhen Wen, Peihao Wen, Jifu Ge, Yang Yang, Tao Zhang, Rangrang Wang

    The success of solid organ transplantation (SOT) and the use of immunosuppressive agents offer hope to patients with end-stage diseases. However, the impact of post-transplant diabetes mellitus (PTDM) on SOT patients has become increasingly evident. In our study, we utilized the Scientific Registry of Transplant Recipients (SRTR) database to investigate the association between PTDM and patient survival in various types of organ transplantations, including liver, kidney, intestinal, heart, lung, and combined heart-lung transplantations (all P<0.001). Our findings revealed a negative effect of PTDM on the survival of these patients. Furthermore, we examined the effects of both generic and innovator immunosuppressive agents on the development of PTDM and the overall survival of different SOT populations. Interestingly, the results were inconsistent, indicating that the impact of these agents may vary depending on the specific type of transplantation and patient population. Overall, our study provides a comprehensive and systematic assessment of the effects of different immunosuppressive agents on prognosis, as well as the impact of PTDM on the survival of patients undergoing various types of SOT. These findings emphasize the need for further research and highlight the importance of optimizing immunosuppressive regimens and managing PTDM in SOT patients to improve their long-term outcomes.


  • Open Access

    A Novel Systematic Oxidative Stress Score Predicts the Survival of Patients with Early-Stage Lung Adenocarcinoma

    by Jia-Yi Qian, Yun Hao, Hai-Hong Yu, Lei-Lei Wu, Zhi-Yuan Liu, Qiao Peng, Zhi-Xin Li, Kun Li, Yu’e Liu, Rang-Rang Wang, et al.

    This study aimed to construct an effective nomogram based on the clinical and oxidative stress-related characteristics to predict the prognosis of stage I lung adenocarcinoma (LUAD). A retrospective study was performed on 955 eligible patients with stage I LUAD after surgery at our hospital. The relationship between systematic-oxidative-stress biomarkers and the prognosis was analyzed. The systematic oxidative stress score (SOS) was established based on three biochemical indicators, including serum creatinine (CRE), lactate dehydrogenase (LDH), and uric acid (UA). SOS was an independent prognostic factor for stage I LUADs, and the nomogram based on SOS and clinical characteristics could accurately predict the prognosis of these patients. The nomogram had a high concordance index (C-index) (0.684, 95% CI, 0.656–0.712), and the calibration curves for recurrence-free survival (RFS) probabilities showed a strong agreement between the nomogram prediction and actual observation. Additionally, the patients were divided into two groups according to the cut-off value of risk points based on the nomogram, and a significant difference in RFS was observed between the high-risk and low-risk groups (p < 0.0001). SOS is an independent prognostic indicator for stage I LUAD. These things considered, the constructed nomogram based on SOS could accurately predict the survival of those patients.